Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00076362
Status:
COMPLETED
Last Update Posted:
2011-09-12
First Post:
2004-01-21
Brief Title:
Pediatric Hypothalamic Obesity
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is being conducted in pediatric patients with Hypothalamic Obesity This generally occurs in people who have had an injury to or tumor in their hypothalamus gland or organ that secretes hormones The purpose of this trial is to see how an investigational treatment controls the hormone insulin by lowering the level of insulin in the body resulting in a weight loss in children who are at least 6 years of age but less than 18 years of age Some children in this trial will receive placebo
To qualify for this study you and your childs doctor must feel that your childs weight is inadequately controlled within a year from the time of injury to the hypothalamus or tumor of the hypothalamus This study will help to determine if an investigational treatment is of benefit in controlling a childs weight
To qualify for this study you and your childs doctor must feel that your childs weight is inadequately controlled within a year from the time of injury to the hypothalamus or tumor of the hypothalamus This study will help to determine if an investigational treatment is of benefit in controlling a childs weight
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None